102 HIV/AIDS vaccines in Russia: clinical trials and estimation of acceptance in population

HIV/AIDS vaccines and also PrEP are considered as the most perspective approaches to control HIV/AIDS epidemic. Candidate conjugated polymer-subunit HIV vaccine VICHREPOL, developed in Moscow Institute of Immunology, successfully passed phase I clinical trials and now is at the start of phase II tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Gudima, G., Sidorovich, I., Karamov, E., Bogachanskaya, N., Pavlov, S., Efimenko, S., Reshetnikov, A., Khaitov, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2014
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149659/
http://dx.doi.org/10.1097/01.qai.0000446683.26826.09

Ejemplares similares

Ejemplares similares